Skip to main content

Article Category

News

Article available in the folowing languages:

Lithuanian biotech growing fast

The Lithuanian biotech sector‘s sales have grown by about 22 % each year for the last 5 years according to the Lithuanian Biotechnology Association.

The success of Lithuanian Biotech is underscored by the fact that the Institute of Biotechnology in Vilnius has attracted back to Lithuania seventeen (17) scientists who have spent over 3 years abroad. They have now returned to carry out their research in Lithuania bringing with them experience, knowledge and funds. The Lithuanian government has increased funding of biotech research in the last five years and established new programs such as the Industrial Biotechnology Program. Very appropriate, this year’s ScanBalt Forum takes place in Vilnius 24-26 September, organized by the Institute of Biotechnology and the Lithuanian Association of Biotechnology and in parallel with the annual ScanBalt Biomaterial Days. Read more at http://www.scanbalt.org/forum2008 The responsible organizer of ScanBalt Forum 2008, dr. Daumantas Matulis, the head of Laboratory of Biothermodynamics and Drug Design, Institute of Biotechnology, says: “The growing importance of life sciences and biotechnology in Lithuania is being recognized with ScanBalt Forum 2008 to take place in Vilnius. This is a chance to promote Lithuania as an attractive place to work, live and invest. We intend to further strengthen our position as a strong player within life sciences and biotechnology in the Baltic Sea Region - also called ScanBalt BioRegion”. For further information contact Daumantas Matulis at: +370 650 06560 or About Institute of Biotechnology: IBT is State Research Institute and the leading biotechnology center in Lithuania active in multidisciplinary studies of restriction - modification enzymes, and the research and development of recombinant biomedical proteins. IBT has 7 laboratories specializing in Protein-DNA Interactions, Biological DNA Modification, Prokaryote Gene Engineering, Eukaryote Gene Engineering, Immunology, Biothermodynamics and Drug Design and Bioinformatics. IBT aims to strengthen the cooperation in the field of Biochemistry, Biotechnology and Biomedicine, enhance networking of academic and industrial sectors and the development of international collaboration and knowledge exchange by maintaining the stimulating competitiveness both in research and commercial applications. IBT boost the initiation of the dialogue with policy makers, best scientific, business leaders on national and international scale. Read more at http://www.ibt.lt About ScanBalt BioRegion and ScanBalt: ScanBalt BioRegion is composed of Life Science and biotechnology actors in the Nordic, Baltic countries, Poland, Northern part of Germany and North western Russia. The ScanBalt BioRegion has 11 countries and 85 million people, more than 60 universities and 2173 life science/biotech companies including 671 research based biotech SME´s. ScanBalt facilitates and co-ordinates regional and national efforts in ScanBalt BioRegion. It enhances visibility and attracts human, industrial and financial resources to the region and to the members. ScanBalt encompasses regional and national life science triple helix networks between companies, universities, hospitals, tech transfer organisations and public authorities. Read more at http://www.scanbalt.org

Countries

Norway